Hum. Reprod. Advance Access originally published online on April 10, 2008
Human Reproduction 2008 23(6):1355-1358; doi:10.1093/humrep/den107
Flexible GnRH antagonist versus flare-up GnRH agonist protocol in poor responders treated by IVF: a randomized controlled trial
1 Eugonia - Iatriki Erevna - IVF unit, 7, Ventiri St, 11528 Athens, Greece 2 Unit for Human Reproduction, Aristotle University of Thessaloniki, Skoufa 5 St, Pilea, 55535 Thessaloniki, Greece 3 Institute for Reproduction and Genetics, Thessaloniki, Greece
4 Correspondence address. Unit for Human Reproduction, 1st Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Skoufa 5 Street, Pilea, Thessaloniki 55535, Greece. Fax: +30 2310 821420; E-mail: stratis.kolibianakis{at}gmail.com
BACKGROUND: Although initial studies in poor responders using GnRH antagonists have reported encouraging results, they are limited in number, only a few of them are prospective, while the majority is characterized by limited power to detect a clinically important difference.
METHODS: A randomized controlled trial was performed in patients with one or more previous failed IVF cycles in which five or less oocytes were retrieved, using 
300 IU of gonadotrophins/day. Patients were randomized by computer-generated list and treated by either the flare-up GnRH agonist protocol (n = 90) or a flexible GnRH antagonist protocol (n = 180).
RESULTS: Ongoing pregnancy rate, the primary outcome measure, was significantly higher in the antagonist group compared with the agonist group (12.2 versus 4.4%, P< 0.048; difference 7.8%, 95% CI: 0.2 to 14.0). Estradiol levels on the day of hCG administration were lower in the antagonist protocol [median (interquartile range): 572 (325–839) versus 727 (439–1029) pg/ml, P = 0.018]. Clinical and biochemical pregnancy rates, fertilization and implantation rates, as well as the number of oocytes retrieved, the number of mature oocytes present, the stimulation period and the gonadotrophin dosage were not significantly different between the two groups compared.
CONCLUSIONS: The flexible GnRH antagonist protocol is associated with significantly higher ongoing pregnancy rates compared with the flare-up GnRH agonist protocol in poor responders (www.clinicaltrials.gov; NCT00417066 [ClinicalTrials.gov] ).
Key words: poor responders/GnRH antagonist/GnRH agonist
Submitted on September 19, 2007; resubmitted on January 27, 2008; accepted on March 10, 2008.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Vuorenoja, B. P. Mohanty, J. Arola, I. Huhtaniemi, J. Toppari, and N. A Rahman Hecate-CG{beta} conjugate and gonadotropin suppression shows two distinct mechanisms of action in the treatment of adrenocortical tumors in transgenic mice expressing Simian Virus 40 T antigen under inhibin-{alpha} promoter Endocr. Relat. Cancer, June 1, 2009; 16(2): 549 - 564. [Abstract] [Full Text] [PDF]
|
|